IOI OLEO GMBH

Abstract Background: Lipid nanoparticles are widely investigated as oral drug delivery systems, but their intestinal performance remains difficult to predict based...

This year CPHI Europe opens its doors in Milan at Fiera Milano. From 6th to 8th October you can have a...

Abstract Although solid oral dosage forms are widely used in adult drug therapy, age-appropriate formulations for pediatric patients remain limited....

Abstract In the pediatric patient group, there is a constant need for individualized dosage forms with precise and adjustable drug...

Lipid-based excipients from IOI Oleo help to improve the bioavailability of poorly soluble active ingredients. The majority of new active...

See the poster by RCPE and IOI Oleo: Lipids: Enormous potential impaired with tough challenges This work investigates the solid-state...

IOI Oleo launched a new family of functional, lipid-based excipients, the polyglycerol esters at CPhI 2025. As the CPhI 2026...

LipoGalen™ 144 – The innovative new base for ovules and suppositories The innovative new base for ovules and suppositories Novelty...

Abstract Drug delivery via aerosolization is a non-invasive and ideal method for targeting the pulmonary system, achieving localized effect. This study aims...

Abstract Mucopolysaccharidosis type I (MPS-I) is a rare, multisystemic lysosomal storage disease (LSD) caused by mutations in the IDUA gene, which encodes...